29/04/09
House dust mites desensitization tablets: Positive results from a phase IIb/III clinical trial
Release of the first year outcome of the VO 57.07 clinical study on a...
15/04/09
1st quarter 2009: favourable developments
Continuing strong growth, successful launch of Oralair® in Germany,...
25/03/09
Webcast - Presentation of 2008 results
Presentation of 2008 results to the financial analysts on 25/03/09
Last update: 15/06/2009
Stallergenes is a European biopharmaceutical laboratory specialising in the treatment by desensitisation of allergy-related respiratory conditions.
The Group's activities focus on research into allergy, and the development, production and distribution of allergen extracts for the curative treatment of allergic rhinitis and asthma.
